A mum from Manchester who was told she only had months to live has now been given the breast cancer all-clear after a groundbreaking drug trial.
51-year-old Jasmin David from Fallowfield was a previously fit and healthy mother of two grown-up children, and was working as a clinical lead at a care home for the elderly, before she discovered that she had an aggressive triple negative form of breast cancer in November 2017 after finding a lump above the nipple.
Following her diagnosis, Jasmin then underwent six months of chemotherapy and a mastectomy in April 2018, followed by 15 cycles of radiotherapy.
These treatments successfully cleared her body of cancer, but sadly, back in October 2019, the cancer returned, and scans showed multiple lesions throughout her body meaning she had a poor prognosis.
ADVERTISEMENT
Jasmin then discovered that the cancer had unfortunately spread to the lungs, lymph nodes, and chest bone, and was given the devastating news that she had less than a year to live.
Two months later, and with no other options left, Jasmin was offered the opportunity to be part of research by participating in the first phase of a two-year groundbreaking clinical trial, which she accepted, and then in December 2019, began treatment at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) at The Christie NHS Foundation Trust in Manchester.
Jasmin David is receiving groundbreaking treatment at The Christie NHS Foundation Trust in Manchester / Credit: The Christie NHS Foundation Trust
During the trial, Jasmin is given an experimental medicine combined with Atezolizumab – an immunotherapy drug administered intravenously – which she continues to have every three weeks.
ADVERTISEMENT
Jasmin says she feels “reborn” after beginning the treatment trial.
And she’s now showing no evidence of the disease, and enjoying life with her husband David and children Ryan and Riona.
“I was 15 months down the line after my initial cancer treatment and had almost forgotten about it, but then the cancer returned,” Jasmin explained.
“When I was offered the trial, I didn’t know if it would work for me, but I thought that at least I could do something to help others and use my body for the next generation. At first I had many horrible side effects including headaches and spiking temperatures, so I was in hospital over Christmas and quite poorly – but then thankfully, I started to respond well to the treatment.
"I take each day as a blessing in my life." Jasmin was diagnosed with cancer and given less than a year to live. But she's now been told she's clear of the disease after taking part in a clinical trial.
By June 2021, scans showed no measurable cancer cells in Jasmin’s body and she was then declared cancer free, but will still remain on treatment until December 2023.
Professor Fiona Thistlethwaite, medical oncologist and clinical director of Manchester CRF at The Christie – who is leading on the study in the UK – said: “We are really pleased that Jasmin has had such a good outcome, and at The Christie, we are continually testing new drugs and therapies to see if they can benefit more people.”
“Darius was found unresponsive in bed in his apartment room in Rochester, Minnesota, on August 11 and was pronounced dead in the afternoon by the local medical examiners’ office.
“The local police department have confirmed that there were no signs of intent or suspicious circumstances. The cause of his sudden death is unknown at this stage while medical examinations continue.
“We ask that you kindly respect our wishes for privacy at this time whilst we come to terms with the tragic loss of our son and brother.”
Featured image: ITV
News
A Japanese fine dining restaurant is opening in the former Randall & Aubin site
Georgina Pellant
A new Japanese fine dining restaurant will open on Bridge Street in Manchester this October, bringing a theatrical ‘multi-sensory’ dining experience to the city.
Giving diners the chance to dine from specially created 7 and 11-course tasting menus or opt for a traditional ‘chef’s choice’ experience at its six-seat Omakase counter, bosses say it will offer a contemporary interpretation of Japanese dishes currently not seen outside of London.
Called MUSU, which translates as ‘infinite possibilities,’ the restaurant is the brainchild of Chef Patron Michael Shaw, who has worked at top eateries including Le Manoir aux Quat’ Saisons and Richard Neat’s eponymous restaurant in Canne.
Image: Supplied
Shaw has spent the last 18 months honing his passion for Japanese cuisine in preparation to open MUSU and will bring on Head Sushi Chef Andre Aguiar, who has trained under renowned Japanese sushi master YugoKato, to head up the kitchen.
When MUSU it opens its doors on Bridge Street on 6 October, diners will be treated to a new tasting menu concept that promises to deliver a ‘multi-sensory dining experience.’
Its menu is divided into three sections – Sentaku, Kaiseki and Omakase – giving diners the choice between ordering dishes a la carte style, opting for a set seven or eleven-course tasting menu, or entrusting the chef to create their ‘perfect menu.’
Served to guests at the six-seat Omakase counter, the latter is presided over by Head Sushi Chef Andre Aguiar.
Drinks-wise, diners can look forward to a mixture of classic cocktails, Japanese sakes and whiskies, as well as a specially chosen list of wines handpicked by house sommelier Ivan Milchev.
As for the new high-end Japanese restaurant’s design, MUSU’s multi-million-pound interiors will boast bespoke Italian furniture, subtle mood lighting and bespoke Geisha-inspired walls, with a bar made from Dekton stone, banana leaf patterned brass and onyx.
Emily Sergeant -
5th July 2022 
